Emerging
Practices that show potential to achieve desirable public health outcomes in a specific real-life setting and produce early results that are consistent with the objectives of the activities and thus indicate effectiveness.

COVID-19 hospitalisation, mortality, vaccination, and postvaccination trends among people with schizophrenia in Israel: a longitudinal cohort study

Tzur Bitan, D., Kridin, K., Cohen, A.D., Weinstein, O.

Release Date:

Peer Review Study

Data Collection and Analysis
Healthcare Access and Quality
Tools Included
Outside U.S.
ACCESS RESOURCE
Clipboard

Data Collection and Reporting

This article details a year-long, longitudinal cohort study of individuals with schizophrenia to examine COVID-19 hospitalization, mortality, vaccination, and postvaccination infection rates. Results show that individuals with schizophrenia are at an increased risk of hospitalization and mortality and have lower rates of vaccination than the general population. Medical comorbidities also play a significant role in worsening outcomes and mortality for this sub-population.

Resource Details

Outcomes of Interest

Reduction of Health Disparities

Priority Population(s)

People With a Mental Illness

Setting(s) of Implementation

Community

Geographic Area of Implementation

Implementation Period

2021